MBVXQ Projected Dividend Yield
MabVax Therapeutics Holdings Inc ( OTCBB : MBVXQ )MabVax Therapeutics Holdings is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of proprietary human monoclonal antibody products and vaccines for the diagnosis and treatment of a variety of cancers. Co.'s clinical development programs are centered around its HuMab-5B1 human antibody, which Co. has tested as a monotherapy, in combination with chemotherapy, and conjugated to radioisotopes in effort to establish safety and tolerability as well as to assess therapeutic benefit for patients diagnosed with pancreatic and other cancers. 20 YEAR PERFORMANCE RESULTS |
MBVXQ Dividend History Detail MBVXQ Dividend News MBVXQ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |